公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2023 | Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial | Llovet, Josep M; Kudo, Masatoshi; Merle, Philippe; Meyer, Tim; Qin, Shukui; Ikeda, Masafumi; Xu, Ruocai; Edeline, Julien; Ryoo, Baek-Yeol; Ren, Zhenggang; Masi, Gianluca; Kwiatkowski, Mariusz; Lim, Ho Yeong; Kim, Jee Hyun; Breder, Valeriy; Kumada, Hiromitsu; ANN-LII CHENG ; Galle, Peter R; Kaneko, Shuichi; Wang, Anran; Mody, Kalgi; Dutcus, Corina; Dubrovsky, Leonid; Siegel, Abby B; Finn, Richard S | The Lancet. Oncology | 19 | | |
2020 | MTL-CEBPA, a small activating RNA therapeutic up-regulating C/EBP-α, in patients with advanced liver cancer: a first-in-human, multi-centre, open-label, phase I trial | Sarker, Debashis; Plummer, Ruth; Meyer, Tim; Sodergren, Mikael; Basu, Bristi; Chee, Cheng Ean; KAI-WEN HUANG ; Palmer, Daniel H; Ma, Yuk Ting; Evans, T R Jeffry; Spalding, Duncan Rc; Pai, Madhava; Sharma, Rohini; Pinato, David J; Spicer, James; Hunter, Sarah; Kwatra, Vineet; Nicholls, Joanna P; Collin, David; Nutbrown, Robert; Glenny, Helen; Fairbairn, Sonia; Reebye, Vikash; Voutila, Jon; Dorman, Stephanie; Andrikakou, Pinelopi; Lloyd, Peter; Felstead, Steve; Vasara, Jenni; Habib, Robert; Wood, Chris; Sætrom, Pål; Huber, Hans E; Blakey, David C; Rossi, John J; Habib, Nagy | Clinical cancer research : an official journal of the American Association for Cancer Research | 74 | 69 | |
2022 | Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma | Rimassa, Lorenza; Kelley, Robin Kate; Meyer, Tim; Ryoo, Baek-Yeol; Merle, Philippe; Park, Joong-Won; Blanc, Jean-Frederic; Lim, Ho Yeong; Tran, Albert; Chan, Yi-Wah; McAdam, Paul; Wang, Evelyn; ANN-LII CHENG ; El-Khoueiry, Anthony B; Abou-Alfa, Ghassan K | Liver cancer | 15 | 14 | |
2022 | Quality of life assessment of cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial | Freemantle, Nick; Mollon, Patrick; Meyer, Tim; ANN-LII CHENG ; El-Khoueiry, Anthony B; Kelley, Robin K; Baron, Ari D; Benzaghou, Fawzi; Mangeshkar, Milan; Abou-Alfa, Ghassan K | European journal of cancer (Oxford, England : 1990) | 2 | 1 | |
2022 | Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child-Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trial | El-Khoueiry, Anthony B; Meyer, Tim; ANN-LII CHENG ; Rimassa, Lorenza; Sen, Suvajit; Milwee, Steven; Kelley, Robin Kate; Abou-Alfa, Ghassan K | BMC cancer | 9 | 9 | |
2023 | Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial | Ren, Zhenggang; Ducreux, Michel; Abou-Alfa, Ghassan K; Merle, Philippe; Fang, Weijia; Edeline, Julien; Li, Zhiwei; Wu, Lihua; Assenat, Eric; Hu, Sheng; Rimassa, Lorenza; Zhang, Tao; Blanc, Jean-Frédéric; Pan, Hongming; Ross, Paul; Yen, Chia-Jui; Tran, Albert; Shao, Guoliang; Bouattour, Mohamed; Chen, Yajin; Meyer, Tim; Hou, Jinlin; Tougeron, David; Bai, Yuxian; Hou, Ming-Mo; Meng, Zhiqiang; Wu, John; Li, Vincent; Chica-Duque, Sandra; ANN-LII CHENG | Liver cancer | 10 | 10 | |
2021 | Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer | Hashimoto, Ayumi; Sarker, Debashis; Reebye, Vikash; Jarvis, Sheba; Sodergren, Mikael H; Kossenkov, Andrew; Sanseviero, Emilio; Raulf, Nina; Vasara, Jenni; Andrikakou, Pinelopi; Meyer, Tim; KAI-WEN HUANG ; ...etc. | Clinical cancer research : an official journal of the American Association for Cancer Research | 45 | 37 | |